» Articles » PMID: 24263896

How Do Nurses in Specialist Palliative Care Assess and Manage Breakthrough Cancer Pain? A Multicentre Study

Overview
Specialties Critical Care
Nursing
Date 2013 Nov 23
PMID 24263896
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To gain a better understanding of how registered nurses working in specialist palliative care assess and manage breakthrough cancer pain.

Methods: A mixed-methodology study was undertaken in two stages-this paper reports findings from stage two. Anonymous postal questionnaires, designed based on themes identified in interviews undertaken during stage one, were sent to trained nurses working in ten specialist palliative care services in England.

Results: A total of 104 questionnaires were returned. Respondents were experienced nurses mainly working in inpatient settings. Some 82% of the nurses wanted more training on the assessment of breakthrough cancer pain. Although there were inconsistencies around the use of terminology, pain management appeared to be good.

Conclusion: The use of terminology in the field of breakthrough cancer pain remains variable. However, this does not appear to have a negative impact on patient management, which was broadly in line with recently published consensus recommendations. There is a desire for more education within this area of practice.

Citing Articles

A systematic review of qualitative research exploring patient and health professional perspectives of breakthrough cancer pain.

Crawford G, Lakhani A, Palmer L, Sebalj M, Rolan P Support Care Cancer. 2023; 31(12):619.

PMID: 37812248 PMC: 10562491. DOI: 10.1007/s00520-023-08076-9.


Canadian recommendations for the management of breakthrough cancer pain.

Daeninck P, Gagnon B, Gallagher R, Henderson J, Shir Y, Zimmermann C Curr Oncol. 2016; 23(2):96-108.

PMID: 27122974 PMC: 4835001. DOI: 10.3747/co.23.2865.


Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).

Porta-Sales J, Perez C, Escobar Y, Martinez V Clin Transl Oncol. 2015; 18(9):945-54.

PMID: 26693731 DOI: 10.1007/s12094-015-1468-7.